Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 2OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 182Leukemia 128Lymphoma 91Leukemia, Myeloid, Acute 83Myelodysplastic Syndromes 64Burkitt Lymphoma 59Lymphoma, Non-Hodgkin 53Lymphoma, Large B-Cell, Diffuse 42Leukemia, Myeloid, Accelerated Phase 39Leukemia, Lymphocytic, Chronic, B-Cell 39Lymphoma, Mantle-Cell 38Hodgkin Disease 38Graft vs Host Disease 36Blast Crisis 35Congenital Abnormalities 34Multiple Myeloma 33Lymphoma, Follicular 33Leukemia, Myeloid, Chronic-Phase 33Myeloproliferative Disorders 32Recurrence 30Breast Neoplasms 29Leukemia, Myelomonocytic, Chronic 28Primary Myelofibrosis 26Lymphoma, Large-Cell, Immunoblastic 26Lymphoma, B-Cell, Marginal Zone 25Neoplasms, Plasma Cell 22Osteosarcoma 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia, Biphenotypic, Acute 20

Interventions

Daunorubicin 2Cytarabine 2prednylidene 1Vincristine 1Prednisolone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Hydrocortisone 1Etoposide 1Epirubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Down Syndrome × Methotrexate × Clear all
NCT03286634 2026-05-11

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

National Hospital Organization Nagoya Medical Center

Phase 2 Active not recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡